Sort by

Send to

Choose Destination

Links from PubMed

Items: 13


Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications.

Hav M, Libbrecht L, Ferdinande L, Geboes K, Pattyn P, Cuvelier CA.

Biomed Res Int. 2015;2015:574540. doi: 10.1155/2015/574540. Epub 2015 Oct 5. Review.


Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum.

Glynne-Jones R, Hava N, Goh V, Bosompem S, Bridgewater J, Chau I, Gaya A, Wasan H, Moran B, Melcher L, MacDonald A, Osborne M, Beare S, Jitlal M, Lopes A, Hall M, West N, Quirke P, Wong WL, Harrison M; Bacchus investigators.

BMC Cancer. 2015 Oct 23;15:764. doi: 10.1186/s12885-015-1764-1.


Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients.

Kye BH, Kim HJ, Kim G, Kim JG, Cho HM.

Cancer Res Treat. 2016 Apr;48(2):561-6. doi: 10.4143/crt.2015.114. Epub 2015 Aug 10.


Oncologic outcomes in rectal cancer with close distal resection margins: a retrospective analysis.

Hong KS, Moon N, Chung SS, Lee RA, Kim KH.

Ann Surg Treat Res. 2015 Jul;89(1):23-9. doi: 10.4174/astr.2015.89.1.23. Epub 2015 Jun 11.


Locally advanced rectal cancer: the importance of a multidisciplinary approach.

Berardi R, Maccaroni E, Onofri A, Morgese F, Torniai M, Tiberi M, Ferrini C, Cascinu S.

World J Gastroenterol. 2014 Dec 14;20(46):17279-87. doi: 10.3748/wjg.v20.i46.17279. Review.


Transrectal ultrasonography of anorectal diseases: advantages and disadvantages.

Kim MJ.

Version 2. Ultrasonography. 2015 Jan [revised 2016 Jan 1];34(1):19-31. doi: 10.14366/usg.14051. Review.


Quality of life, pain, anxiety and depression in patients surgically treated with cancer of rectum.

Santos LJ, Garcia JB, Pacheco JS, Vieira EB, Santos AM.

Arq Bras Cir Dig. 2014 Apr-Jun;27(2):96-100. English, Portuguese.


Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer.

Naiken SP, Toso C, Rubbia-Brandt L, Thomopoulos T, Roth A, Mentha G, Morel P, Gervaz P.

BMC Surg. 2014 Jan 17;14:4. doi: 10.1186/1471-2482-14-4.


Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis.

Hartman RI, Chang CY, Wo JY, Eisenberg JD, Hong TS, Harisinghani MG, Gazelle GS, Pandharipande PV.

Acad Radiol. 2013 Jan;20(1):79-89. doi: 10.1016/j.acra.2012.07.010. Epub 2012 Sep 2.


Post-treatment surveillance in colorectal cancer.

Velenik V.

Radiol Oncol. 2010 Sep;44(3):135-41. doi: 10.2478/v10019-010-0018-8. Epub 2010 Sep 9.


Approach to rectal cancer surgery.

Chua TC, Chong CH, Liauw W, Morris DL.

Int J Surg Oncol. 2012;2012:247107. doi: 10.1155/2012/247107. Epub 2012 Jun 25.


Management of stage IV rectal cancer: palliative options.

Ronnekleiv-Kelly SM, Kennedy GD.

World J Gastroenterol. 2011 Feb 21;17(7):835-47. doi: 10.3748/wjg.v17.i7.835. Review.


International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams.

Augestad KM, Lindsetmo RO, Stulberg J, Reynolds H, Senagore A, Champagne B, Heriot AG, Leblanc F, Delaney CP; International Rectal Cancer Study Group (IRCSG).

World J Surg. 2010 Nov;34(11):2689-700. doi: 10.1007/s00268-010-0738-3.

Items per page

Supplemental Content

Support Center